Lv1
70 积分 2025-02-02 加入
CD47-SIRPα Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells
2天前
已完结
CD47-SIRPα Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells
2个月前
已完结
Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy
3个月前
已完结
The Interplay between Metabolic Adaptations and Diet in Cancer Immunotherapy
3个月前
已完结
Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results
3个月前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
3个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
4个月前
已完结
Advances in tumor micro-environment and immunotherapy of squamous cell carcinoma of the tongue
4个月前
已完结
Head and neck squamous cell carcinoma
7个月前
已完结
皖公网安备34019202002308
